Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tiedotteet
22250
Valikko

Feeling ’22: Mary Kay Inc. Announces Awards, Milestones, and Accomplishments From First Half of the Year28.7.2022 20:02:00 EEST | Press release

Mary Kay Inc. is feeling ’22. Throughout the first half of the year, the iconic global entrepreneurship company has furthered its innovations in skin science, continued its social impact efforts, and garnered several prestigious awards for its business and leadership. It’s a thing of beauty—and the nearly 60-year-old brand is just getting started. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005228/en/ Mary Kay logo (Graphic: Mary Kay Inc.) 2022 AWARDS & HIGHLIGHTS 30 total awards for business excellence, social impact and sustainability 10 employer awards recognizing Mary Kay as a great place to work and for operational excellence 7 awards for Mary Kay’s c-suite and senior leadership 17 self-released reports reinforcing Mary Kay’s operational and philanthropic efforts supporting its sustainability commitments for its Enriching Lives Today for a Sustainable Tomorrow strategy 3 mentions in annual reports from social i

Asaf Ashkenazi Named CEO of Verimatrix28.7.2022 19:00:00 EEST | Press release

Regulatory News: Verimatrix (Euronext Paris: VMX) (Paris:VMX), today announced the appointment of Asaf Ashkenazi as Chief Executive Officer effective Monday, August 1st, 2022. Amedeo D’Angelo, Chairman and Chief Executive Officer since 2015, remains Executive Chairman of Verimatrix effective the same day. Asaf Ashkenazi joined Verimatrix in 2018 and currently serves as Chief Operating Officer. He will lead the company’s ongoing business model transformation announced last year that focuses on recurring subscription-based revenue sources and new products. “This evolution and reinforcement of the Verimatrix governance structure aligns well with the company’s needs as we further the progression of our business model,” Amedeo D’Angelo said. “I look forward to working closely with Asaf in his newly expanded role as CEO during this strategic development of Verimatrix.” Previously leading the company’s R&D, product, sales and marketing operations, Asaf Ashkenazi will continue to harness his d

GUESS Heads to Granada for the 2022 Fall/Winter Advertising Campaign28.7.2022 18:00:00 EEST | Press release

The new GUESS Fall-Winter 2022 advertising campaign sees the brand off to explore the history-steeped streets of Granada, Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005098/en/ GUESS Heads to Granada for the 2022 Fall/Winter Advertising Campaign (Photo: Business Wire) The FW22 campaign is immortalized through the lens of fashion photographer Tatiana Gerusova, under the guidance of GUESS?, Inc.’s Chief Creative Officer, Paul Marciano. The new campaign features a sizzling lineup: German-born, Polish fashion model Kim Dammer, Serbian model Nina Kostić, Spanish model Lidia Santos, Italian model Mario Ermito, and French model Xavier Grey. GUESS Women The campaign showcases an enticing array of GUESS pieces, highlighting must-have accessories and elevated animal and botanical prints. The collection brings a fresh and youthful breeze of contemporary color and style to grey winter days. Against the alluring continent

Innovaderm Bolsters European Presence With Two Newly-Established Operations Hubs (Spain & Poland)28.7.2022 17:00:00 EEST | Press release

Innovaderm announced today that its strategic European expansion initiative has reached a major milestone with the launch of two key centres of operations in Poland and Spain. Biotechnology and pharmaceutical companies can officially partner with the CRO’s team of experts in Europe to manage clinical trials in psoriasis, acne, atopic dermatitis and other dermatology indications. This includes adherence to stringent regulatory requirements, patient recruitment, site selection, clinical monitoring and protocol writing. “To date, we have successfully completed more than 500 clinical trials at 2,900 sites,” says Dave Selkirk, Innovaderm’s Chief Operating Officer. “The presence of two operations hubs in Europe will allow us to go one step further and accelerate the development of promising therapies that have the potential to transform lives. As we look to the future, our goal is to continue supporting innovation in research and the increasing number of patients with skin conditions worldwi

Echosens Partners with World Hepatitis Alliance on World Hepatitis Day, July 28, Urges Importance of Testing and Treatment28.7.2022 16:07:00 EEST | Press release

Echosens, a high-technology company offering liver diagnostic solutions, establishes its support of World Hepatitis Day (WHD), July 28 by partnering with the World Hepatitis Alliance as a bronze sponsor. The commemoration calls for greater awareness of the 357 million people who live with viral hepatitis but are unaware of it. The campaign’s theme “I can’t wait” highlights the need to accelerate the fight against viral hepatitis and the importance of testing and treatment for the real people who need it. “Echosens recognizes that every 30 seconds, someone in the world dies from a hepatitis-related illness, and we join hands with organizations throughout the world to advance increased vigilance around liver health,” says Dominque Legros, Echosens Group CEO. “It is gratifying to see that this year's theme for World Hepatitis Day aligns with our mission for early detection that can result in more effective intervention, treatment and better outcomes.” Viral hepatitis is an inflammation of

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership28.7.2022 15:00:00 EEST | Press release

Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005025/en/ Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years serving in a variety of operational and commercial leadership positions, and most recently served as Senior Vice President, Commercial and Strategic Development. (Photo: Business Wire) Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years serving in a variety of operational and commercial leadership positions, and most recently served as Senior Vice President, Commercial and Strategic Development. Building on the company’s conti

Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate28.7.2022 14:30:00 EEST | Press release

Organon (NYSE: OGN), a global women’s healthcare company, and Cirqle Biomedical today announced they have entered into a research collaboration and exclusive license agreement for a novel investigational non-hormonal, on-demand contraceptive candidate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005145/en/ “As a leader in contraception, we believe it is critically important to bring forward new options for women, especially in the space of non-hormonal contraceptives, a category preferred by many with limited available options,” said Sandra Milligan, M.D., Organon’s head of Research and Development. “Organon is committed to driving innovation across women’s health and collaborating with companies like Cirqle Biomedical to support early science and bring forward new solutions that address the unmet needs of women.” Encouraging preclinical research suggests that Cirqle has discovered a method that has the potential to

Animol Discovery, Inc. Announces Series B Financing of $34.0 million to Advance Its Pipeline of Novel Veterinary Pharmaceuticals28.7.2022 14:07:00 EEST | Press release

Animol Discovery, Inc., a pioneer in veterinary pharmaceutical discovery, today announced it has raised $34.0 million in Series B financing. The investment was led by Novalis Lifesciences, with participation from Finistere Ventures and existing investor Anterra Capital. The proceeds allow the company to expand and advance its pipeline of novel active pharmaceutical ingredients through clinical development and further enhance its cutting-edge drug discovery platform. The $40Bn animal health industry continues to demand novel medicines to treat infectious and chronic diseases in companion and production animals. Recent successes, such as Apoquel™ from Zoetis and Nexguard™ from Boehringer Ingelheim, demonstrate the potential to build towards blockbuster franchises in the sector with novel pharmaceutical products. “Pet parents and livestock farmers continue to demand novel veterinary pharmaceuticals that can protect animals against diseases and improve quality of life,” said Andrew Plant P

Reopening of Black Sea a welcome relief, but while Ukraine remains volatile, latest data shows industry adapting28.7.2022 10:44:00 EEST | Press release

With news of last week’s UN deal to reopen the Black Sea, allowing ocean grain shipments to resume from Ukraine, leading real-time supply chain visibility platform FourKites® released new data showing that agile shippers are finding ways of managing the volatile situation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005468/en/ FourKites data shows increased shipments to countries bordering Russia and Ukraine (Graphic: Business Wire) Following Friday’s grain deal between Ukraine and Russia, FourKites expects grain shipments from Black Sea ports to resume within a few days. The same deal allows Russia to export fertiliser and other products not covered by international sanctions. “My hope is that this agreement gives big shipping companies the confidence to resume operations in the region,” says Philippe Salles, FourKites’ VP Strategic Solutions (Ocean). “The next few weeks will be telling. But if things go well, this

Servify Secures SOC 2 Type II Certification28.7.2022 10:30:00 EEST | Press release

Servify, a global product lifecycle management platform, has successfully received the internationally acclaimed System and Organization Controls 2 (SOC 2) Type II certification. This achievement reflects Servify’s commitment to the highest levels of data compliance and security. Developed by the American Institute of Certified Public Accountants (AICPA), SOC 2 Type II report on Servify, verifies the existence of internal controls which have been designed and implemented to meet the requirements for the security principles set forth in the Trust Services Principles and Criteria for Security. It provides a thorough review of how Servify’s internal controls affect the security, availability, and processing integrity of the systems it uses to process both partner and it’s users’ data, along with confidentiality and privacy of the information processed by these systems. Servify passed the audit evaluation in less than three months, solidifying its pledge towards data compliance and securit

SES and AXESS Networks to Enable Smart Mining with O3b mPOWER28.7.2022 09:50:00 EEST | Press release

SES and AXESS Networks (AXESS), a leading provider of satellite connectivity solutions, are accelerating digital transition of the mining industry with SES’s second-generation medium earth orbit (MEO) system O3b mPOWER, the two companies announced today. Under this multi-year, multi-million agreement, the mining sector users will be able to benefit from the cutting-edge low-latency Onshore Energy & Mining mPOWERED connectivity service. SES’s Onshore Energy & Mining mPOWERED service will provide the highest throughput available from a satellite system and deliver dedicated and carrier-grade networks to AXESS’ customers reliably regardless of their remote locations. O3b mPOWER can deliver up to multiple gigabits per second per site, enabling AXESS’ customers to accelerate the digitalisation of their operations and sites globally, boosting profitability through access to new applications and efficiency, as well as improving staff safety and welfare. SES’s second-generation MEO connectivit

Veracode Expands Platform Capabilities in its EU-Resident Platform28.7.2022 09:50:00 EEST | Press release

Veracode, a leading global provider of application security testing solutions, today announced the enhancement of its Continuous Software Security Platform in Europe. Companies can now secure their software across the entire software development lifecycle (SDLC) with the added capabilities of dynamic analysis and API scanning, complementing Veracode’s static analysis, software composition analysis and manual penetration testing tools. The Veracode European Region, a cloud-based instance, allows customer data to stay resident in the EU to meet policy requirements for cloud computing. Demand for a SaaS-based software security solution that supports data residency has never been greater. With a 20x increase* in security scanning cadence over the past decade, organisations are now testing apps for flaws more thoroughly than ever. Many are shifting further left and combining static, dynamic, and software composition analysis to gain a comprehensive view of risk and compliance to policies. V

Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards Full-Year Management Guidance28.7.2022 09:00:00 EEST | Press release

Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2022 (period ended June 30, 2022) and is on track to meet its full-year management guidance. The gain on the sale of Takeda’s Japan diabetes portfolio in the first quarter of the previous fiscal year has impacted reported financial results on a year-over-year basis, as expected. The sale contributed a one-off 133 billion yen to revenue and 131.4 billion yen to operating profit in Q1 FY2021. This impact is excluded from core financial results; the Company delivered +8.3% core revenue growth and +17% core operating profit growth at CER this quarter, with a core operating profit margin of 32.8%. Takeda chief financial officer, Costa Saroukos, commented: “Takeda has delivered strong first quarter performance with Growth and Launch Products continuing to drive robust core revenue growth. Our results reflect continued momentum and solid commercial execution across key business areas.” “

NTT Joins the Joint Audit Cooperation (JAC) along with Telecommunications Carriers of the Global ICT Supply Chain28.7.2022 09:00:00 EEST | Press release

NTT CORPORATION (NTT) has joined the Joint Audit Cooperation (JAC) 1, which conducts CSR audits of Information and Communication Technology (ICT) suppliers globally. NTT is the first Asian telecommunications carrier to join the association and will contribute to realizing a sustainable society by building and maintaining a safe and secure supply chain. JAC Overview Established in 2010, JAC currently consists of 23 telecommunications companies, including NTT 2. Since its inception, JAC members have conducted more than 724 Corporate Social Responsibility (CSR) audits in 41 countries. Telecommunications carriers who promote cooperative audits have a track record of improving CSR standards throughout the supply chain. NTT Participation In February 2022, NTT announced the NTT Group Guidelines for Sustainability in Supply Chain 3. The company has been boosting engagement with suppliers to build and maintain safe and secure supply chains. As the first Asian telecommunications carrier to join

Valbiotis Announces Completion of Recruitment for the Phase II/III REVERSE-IT Clinical Study With TOTUM•63 Against Prediabetes, in Partnership With Nestlé Health Science28.7.2022 08:35:00 EEST | Press release

Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces that it has completed the recruitment of 600 volunteers for the international multicenter Phase II/III REVERSE-IT clinical study on TOTUM•63. This randomized, placebo-controlled study evaluates the efficacy of TOTUM•63, a plant-based active substance, in a population with impaired glucose metabolism, from prediabetes to untreated type 2 diabetes (early stage). The primary objective will be the reduction of fasting blood glucose levels after 24 weeks of TOTUM•63 supplementation compared to placebo. The results will be communicated at the end of the study. The Phase II/III REVERSE-IT study was co-designed by the Valbiotis and Nestlé Health Science medical and regulatory teams to demonstrate the efficacy of TOTUM•63 against prediabetes and untreated type 2 diabe

Anheuser-Busch InBev Reports Second Quarter 2022 Results28.7.2022 08:07:00 EEST | Press release

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727006135/en/ (Graphic: Business Wire) Regulated and inside information1 Continued momentum with double-digit top-line growth “Our business delivered sustained profitable growth. Our volume increased by 3.4%, our top-line by 11.3% and EBITDA by 7.2%. The relentless execution of our strategy, the strength of our brands and accelerated digital transformation enabled us to meet the moment in an ongoing dynamic operating environment.” - Michel Doukeris, CEO Total Revenue +11.3% Revenue increased by 11.3% in 2Q22 with revenue per hl growth of 7.5% and by 11.5% in HY22 with revenue per hl growth of 7.9%. 9.7% increase in combined revenues of our global brands, Budweiser, Stella Artois and Corona, outside of their respective home markets in 2Q22, and 7.9% in HY22. Approximately 55% of our revenue now through B2B digi

ADVA increases revenues for Q2 202228.7.2022 08:00:00 EEST | Press release

ADVA (ISIN: DE0005103006, FSE: ADV), a leading provider of open networking solutions for the delivery of cloud and mobile services, reported final financial results for Q2 2022 ended on June 30, 2022. The results have been prepared in accordance with International Financial Reporting Standards (IFRS). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727005735/en/ Brian Protiva, CEO, ADVA (Photo: Business Wire) Q2 2022 financial summary 1 (in thousands of EUR) Q2 2022 Q2 2021 Change Q1 2022 Change Revenues 166,320 149,354 11.4% 170,498 (2.5)% Pro forma gross profit 54,336 57,274 (5.1)% 53,405 1.7% in % of revenues 32.7% 38.3% (5.6) pp 31.3 % 1.4 pp Pro forma EBIT 6,435 14,415 (55.4)% 7,812 (17.6)% in % of revenues 3.9% 9.7% (5.8) pp 4.6% (0.7) pp Operating income 2 4,655 13,036 (64.3)% 5,976 (22.1)% Net income 7,291 12,001 (39.2)% 6,179 18.0% (in thousands of EUR) Jun. 30, 2022 Jun. 30, 2021 Change Mar. 31, 2022 Change Cash

Suzano Reports a Strong Second Quarter Performance With Record Cash Generation28.7.2022 00:30:00 EEST | Press release

Suzano , one of the world’s largest integrated pulp and paper producers, announces its second quarter results for 2022. Adjusted EBITDA of R$6.3 billion, up 6% on 2Q21 (R$5.9 billion) Operating cash generation of R$5.1 billion, up 2% on 2Q21 (R$4.9 billion) Net revenue of R$11.5 billion, up 17% on 2Q21 (R$9.8 billion) Substantial sales volume increase: 5% increase in pulp sales volumes to 2.66 million tons (2Q21: 2.54 million tons) 10% increase paper sales volumes to 324,000 tons (2Q21: 296,000 tons) Net debt to EBITDA leverage ratio of 2.3x (1Q22: 2.4x) Increased 2022 CAPEX guidance of R$16.1 billion from previously announced R$13.6 billion Strong second quarter performance across these financial verticals was driven by both higher sales prices, given more favourable market conditions for pulp and paper markets; and higher sales volumes, given fewer scheduled maintenance shutdowns. Cost management discipline also improved adjusted EBITDA and cash generation. “These excellent second qu

Rimini Street Launches Rimini Protect™ Security Suite to Better Protect Organizations From Continuously Evolving Cybersecurity Threats27.7.2022 23:38:00 EEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, has launched Rimini Protect™, a new suite of security solutions that is always on 24x7x365 and provides a more comprehensive layer of security that surrounds and protects enterprise IT infrastructure and applications. For years, Rimini Street has provided proven and proactive advanced “zero-day” security solutions for our clients’ enterprise software applications, middleware, and databases, and these solutions are now available with additional new offerings in the new Rimini Protect suite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727006028/en/ Rimini Street Launches Rimini Protect™ Security Suite to Better Protect Organizations From Continuously Evolving Cybersecurity Threats (Graphic: Business Wire) Security Prote

What’s Next for Autonomous Driving? Mouser’s Empowering Innovation Together Explores AI-Based Driver Monitoring27.7.2022 18:50:00 EEST | Press release

Mouser Electronics Inc., the industry’s leading New Product Introduction (NPI) distributor with the widest selection of semiconductors and electronic components™, has released the latest chapter of its award-winning Empowering Innovation Together™ program. The new episode explores the importance of driver monitoring systems for occupant presence and condition — such as fatigue or distraction — to help foster the safety required for Level 3 autonomous driving and beyond. Content for this fourth installment includes two articles, a blog, an infographic, a new episode of the Tech Between Us podcast and a Then, Now and Next video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220727005696/en/ The fourth installment of Mouser's 2022 Empowering Innovation Together program explores AI-based driver monitoring systems for occupant presence and condition — such as fatigue or distraction — and includes a new episode of The Tech Betwee
  • 1
  • 2
  • 3
  • 4
  • 5
  • Viimeinen
  • >>

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.